Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir

Efficacy of favipiravir (T-705) in nonhuman primates infected with Ebola virus or Marburg virus

(2018) Sandra L. Bixler et al.   ANTIVIRAL RESEARCH

Favipiravir as a potential countermeasure against neglected and emerging RNA viruses

(2018) Leen Delang et al.   ANTIVIRAL RESEARCH

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

(2018) Maria L. Agostini et al.   mBio

Recombinant RNA-Dependent RNA Polymerase Complex of Ebola Virus

(2018) Egor P. Tchesnokov et al.   Scientific Reports

Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques

(2018) Jérémie Guedj et al.   PLOS MEDICINE

Initiation, extension, and termination of RNA synthesis by a paramyxovirus polymerase

(2018) Paul C. Jordan et al.   PLoS Pathogens

ANTIBODY-MEDIATED PROTECTIVE MECHANISMS INDUCED BY A TRIVALENT PARAINFLUENZA-VECTORED EBOLAVIRUS VACCINE

(2018) J. Brian Kimble et al.   JOURNAL OF VIROLOGY

Antibody-mediated protection against Ebola virus

(2018) Erica Ollmann Saphire et al.   NATURE IMMUNOLOGY

Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses

(2017) Dustin Siegel et al.   JOURNAL OF MEDICINAL CHEMISTRY

Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase

(2017) Yousuke FURUTA et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Polymerases of paramyxoviruses and pneumoviruses

(2017) Rachel Fearns et al.   VIRUS RESEARCH

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo- and Paramyxoviruses

(2017) Michael K. Lo et al.   Scientific Reports

Ribavirin revisited in the era of direct-acting antiviral therapy for hepatitis C virus infection

(2016) Jordan J. Feld et al.   LIVER INTERNATIONAL

Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys

(2016) Travis K. Warren et al.   NATURE

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

(2016) Daouda Sissoko et al.   PLOS MEDICINE

Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2′-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases

(2015) Zhinan Jin et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies

(2015) Edgar Davidson et al.   JOURNAL OF VIROLOGY

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial

(2015) Ana Maria Henao-Restrepo et al.   LANCET

Molecular Basis for the Selective Inhibition of Respiratory Syncytial Virus RNA Polymerase by 2'-Fluoro-4'-Chloromethyl-Cytidine Triphosphate

(2015) Jerome Deval et al.   PLoS Pathogens

Efficiency of Incorporation and Chain Termination Determines the Inhibition Potency of 2′-Modified Nucleotide Analogs against Hepatitis C Virus Polymerase

(2014) Amy Fung et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model

(2014) Lisa Oestereich et al.   ANTIVIRAL RESEARCH

High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses

(2014) Luke S. Uebelhoer et al.   ANTIVIRAL RESEARCH

Post-exposure efficacy of Oral T-705 (Favipiravir) against inhalational Ebola virus infection in a mouse model

(2014) Sophie J. Smither et al.   ANTIVIRAL RESEARCH

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp

(2014) Xiangguo Qiu et al.   NATURE

Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430

(2014) Travis K. Warren et al.   NATURE

Inhibition of viral RNA polymerases by nucleoside and nucleotide analogs: therapeutic applications against positive-strand RNA viruses beyond hepatitis C virus

(2014) Jerome Deval et al.   Current Opinion in Virology

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

(2013) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase

(2013) Zhinan Jin et al.   PLoS One

Critical phosphoprotein elements that regulate polymerase architecture and function in vesicular stomatitis virus

(2012) A. A. Rahmeh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Respiratory Syncytial Virus Polymerase Has Multiple RNA Synthesis Activities at the Promoter

(2012) Sarah L. Noton et al.   PLoS Pathogens

Human Mitochondrial RNA Polymerase: Evaluation of the Single-Nucleotide-Addition Cycle on Synthetic RNA/DNA Scaffolds

(2011) Eric D. Smidansky et al.   BIOCHEMISTRY

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections

(2009) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

Delayed Chain Termination Protects the Anti-hepatitis B Virus Drug Entecavir from Excision by HIV-1 Reverse Transcriptase

(2008) Egor P. Tchesnokov et al.   JOURNAL OF BIOLOGICAL CHEMISTRY